Earnings History Data for Redhill Biopharma Ltd. (RDHL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Redhill Biopharma Ltd.

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
23-06-2022	PM	8:00 AM ET (Jun 23)	RDHL	Redhill Biopharma Ltd.	35.98	-0.30	-0.40	-0.53	RedHill GAAP EPS of -$0.03 in-line, revenue of $18.2M misses by $5.4M [6/23/2022 8:26 AM]	0.77	0.0 (0.44%)	1.02	0.25 (33.06%)	0.62 - 11.18	29,589,358	1,510,000	25,572,446
RedHill GAAP EPS of -$0.03 in-line, revenue of $18.2M misses by $5.4M [6/23/2022 8:26 AM] RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22 [Jun-23-22 07:00AM]
17-03-2022	PM	(Feb 17)	RDHL	Redhill Biopharma Ltd.	86.46	-0.50	-0.40	-0.70	RedHill GAAP EPS of -$0.21 beats by $0.78, revenue of $85.76M misses by $2.14M [3/17/2022 8:08 AM]	2.26	0.43 (23.50%)	1.95	0.12 (6.56%)	1.60 - 11.18	862,591	454,445	6,375
RedHill GAAP EPS of -$0.21 beats by $0.78, revenue of $85.76M misses by $2.14M [3/17/2022 8:08 AM] RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results [Mar-17-22 07:59AM]
30-11-2021	PM	7:00 AM ET (Nov 30)	RDHL	Redhill Biopharma Ltd.	133.17	-0.46	-0.48	-0.50	RedHill EPS beats by $0.27, misses on revenue [11/30/2021 7:05 AM]	2.93	0.14 (4.82%)	2.91	0.11 (3.93%)	2.57 - 11.52	874,088	1,190,000	191,321
RedHill Q3 2021 Earnings Preview: What to Expect [11/29/2021 11:33 AM] RedHill EPS beats by $0.17, misses on revenue [11/30/2021 7:05 AM] RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results [Nov-30-21 07:00AM] RedHill Reports 3Q/2021 Financial Results [Nov-30-21 07:02AM]
26-08-2021	PM	7:00 AM ET (Aug 26)	RDHL	Redhill Biopharma Ltd.	321.43	-0.62	-0.40	-0.45	RedHill EPS beats by $0.15, misses on revenue [8/26/2021 7:03 AM]	7.24	0.06 (0.84%)	7.49	0.31 (4.32%)	5.90 - 11.52	1,545,829	320,000	1,337,529
RedHill jumps 18% after Opaganib shows inhibition of COVID-19 Delta variant [8/26/2021 6:41 AM] RedHill EPS beats by $0.15, misses on revenue [8/26/2021 7:03 AM] RedHill shares rise after opaganib preclinical data, Q2 results [8/26/2021 10:11 AM] RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant [Aug-26-21 06:00AM] RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition [Aug-26-21 06:30AM] RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights [Aug-26-21 07:00AM] RedHill Reports Second Quarter 2021 Results [Aug-26-21 07:30AM] RedHill Biopharma's Oral COVID-19 Candidate Shows Preclinical Action Against Delta Variant [Aug-26-21 08:44AM]
27-05-2021	PM	7:00 AM ET (May 27)	RDHL	Redhill Biopharma Ltd.	329.00	-0.53	-0.46	-0.49	RedHill EPS beats by $0.29, misses on revenue [5/27/2021 7:03 AM]	7.11	0.07 (0.92%)	7.12	0.07 (0.99%)	5.91 - 11.52	612,546	240,000	21,973
RedHill gets U.S. patent application allowances for opaganib and RHB-107 in COVID-19 [5/26/2021 8:16 AM] RedHill EPS beats by $0.29, misses on revenue [5/27/2021 7:03 AM] RedHill Biopharma Q1 loss narrows amid uptick in prescription volumes [5/27/2021 11:09 AM] 3 Strong Buy Stocks Under $10 With Triple-Digit Upside Potential [May-26-21 11:06AM] RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19 [May-26-21 07:12AM] RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19 [May-26-21 07:00AM] RedHill Biopharma Ltd. to Host Earnings Call [May-27-21 06:45AM] RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights [May-27-21 07:00AM] Strength Seen in Redhill Biopharma Ltd. (RDHL): Can Its 5.4% Jump Turn into More Strength? [May-27-21 07:05AM] 35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021 [May-27-21 07:15PM]
18-03-2021	PM	7:00 AM ET (Mar 18)	RDHL	Redhill Biopharma Ltd.	3,670	-0.70	-0.50	-0.30	RedHill misses on revenue [3/18/2021 7:02 AM]	7.41	-0.51 (-6.44%)	7.75	-0.17 (-2.15%)	3.26 - 11.52	612,755	420,000	11,603
RedHill misses on revenue [3/18/2021 7:02 AM] Recap: Redhill Biopharma Q4 Earnings [Mar-18-21 08:18AM]
12-11-2020	PM	7:00 AM ET (Nov 12)	RDHL	Redhill Biopharma Ltd.	306.75	-0.50	-0.22	-0.30	RedHill EPS beats by $0.11, misses on revenue [11/12/2020 7:02 AM]	7.77	-0.45 (-5.47%)	8.10	-0.12 (-1.46%)	3.26 - 11.35	328,040	208,806	7,828

13-08-2020	PM	7:00 AM ET (Aug 13)	RDHL	Redhill Biopharma Ltd.	316.37	-0.45	-0.14	-0.38	RedHill EPS beats by $0.03, misses on revenue [8/13/2020 7:05 AM]	8.46	-0.74 (-8.00%)	9.60	0.41 (4.46%)	3.26 - 10.17	602,216	683,552	92,707

27-05-2020	PM	7:00 AM ET (May 27)	RDHL	Redhill Biopharma Ltd.	259.58	-0.49	-0.38	-0.35	RedHill EPS beats by $0.55, misses on revenue [5/27/2020 7:06 AM]	6.98	-0.20 (-2.86%)	7.11	-0.07 (-0.97%)	3.26 - 9.12	342,233	302,549	11,011